Navigation Links
VetStem Biopharma Shares the Story of San Fransisko Who Advanced in His Dressage Career After Being Treated with VetStem Cell Therapy
Date:3/5/2019

San Fransisko, or Sisko for short, is a German warmblood with an impressive pedigree. His owner, Deborah, purchased him at four years old to pursue a career in dressage. According to Deborah, dressage came easy to Sisko and his trainer commented that he was the most talented horse that she’d ever worked with. Unfortunately, Sisko suffered an injury while playing in his pasture. Deborah reported that he jammed his neck and suddenly refused to go forward leading Deborah to seek medical attention.

After several visits to an equine lameness expert and numerous diagnostic tests, it was determined that a few of Sisko’s neck vertebrae were malformed, causing pain in his neck and rendering him unable to work in his chosen field. Cervical facet disease can be caused by developmental conditions and/or injuries which can lead to osteoarthritis and spinal compression in the neck. Conventional treatments for the degenerative joints may reduce inflammation and pain but ongoing degeneration of the facet joints and their supportive structures can occur, leading to eventual worsening of pain and symptoms.

Fortunately, Sisko qualified for a clinical research program that is being conducted by VetStem to study the effects of VetStem Regenerative Cell Therapy on horses with cervical facet disease. To begin the process, Sisko’s veterinarian collected fat from Sisko’s tailhead and shipped it to the VetStem laboratory in San Diego, California for processing. VetStem laboratory technicians aseptically processed the fat to extract the stem cells and create injectable doses of Sisko’s own stem and regenerative cells. These doses were shipped back to Sisko’s veterinarian for injection into the affected joints and also intravenously. Due to the severity of Sisko’s case, he received a follow up treatment approximately six weeks after the initial treatment.

According to Deborah, Sisko began to improve and slowly went back to work after a lengthy rehab. He eventually regained complete mobility in his neck in both directions and was able to resume his training. In one year, he moved up from Training Level to First Level and in 2018, completed his first full year of showing. He ended the year as First Level Champion for the California Dressage Society, Temecula Valley Chapter, in both of their series of Rated and Schooling shows. He also won their award for High Score in a Single Test for both the Rated and Schooling shows as well as the Chapter’s Warmblood breed award. Deborah stated, “Without a doubt, Sisko would not have recovered and been able to resume his dressage career if he hadn’t received the stem cell treatments. I’m very grateful to my knowledgeable veterinarian for his continued help with Sisko and to VetStem for storing his stem cell reserves in case he needs them in the future.”

Stem cells are regenerative cells that can differentiate into many tissue types, reduce pain and inflammation, help to restore range of motion, and stimulate regeneration of tendon, ligament and joint tissues. Sisko’s case was handled under a VetStem clinical research program, in an effort to gain more information about stem cell use for this condition. Any inquiries regarding treatment of similar conditions or other non-orthopedic indications should be directed to VetStem clinical research personnel.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_biopharma_shares_the_story_of_san_fransisko_who_advanced_in_his_dressage_career_after_being_treated_with_vetstem_cell_therapy/prweb16144354.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma Launches Human Stem Cell Company in San Diego
2. VetStem Biopharma is Pleased to Announce Dr. Douglas Stramel of Advanced Care Veterinary Services is Successfully Using the Pall V-PET™ Platelet Therapy System
3. VetStem Biopharma is Pleased to Share the Success Story of Rascal who was Treated with VetStem Cell Therapy by Dr. Deborah Fegan
4. Veterinarian Dr. Patrick Leadbeater Brings VetStem Regenerative Cell Therapy to the Island of Kauai
5. VetStem Biopharma Shares News of the Successful Treatment of Partially Torn Cruciate Ligament in Young Labrador Retriever with the Pall V-PET™ Platelet Therapy System
6. VetStem Biopharma CEO, Dr. Robert Harman, will Present Data on Stem Cells for Kidney Disease in Poster Session at Feline Veterinary Conference
7. CEO of VetStem Biopharma, Dr. Robert Harman, to Present Results of Safety Study for Allogeneic Stem Cell Product at Regenerative Medicine Conference
8. New Patent for Adipose Stem Cells Issued to VetStem Biopharma
9. Dr. Bob Harman, CEO of VetStem Biopharma, Speaks on Stem Cells at Local Rotary Club
10. Dr. Bob Harman of VetStem Biopharma to Speak on the Business of Stem Cells at the Wild West Veterinary Conference
11. VetStem Biopharma CEO and Founder, Dr. Bob Harman, Interviewed in New Book "Stem Cell Therapy: A Rising Tide"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/10/2019)... ... April 10, 2019 , ... ... have locked into multiple agreements to help companies advance their innovations to ... industry, ranging from synthetic biology companies that are gene editing therapeutic cells ...
(Date:4/9/2019)... ... ... The American Society of Gene & Cell Therapy (ASGCT) is excited to ... the presidential line of succession, at the 22nd Annual Meeting . Members of ... three-year term (2019-2021). , All five incoming members of the ASGCT Board of ...
(Date:4/4/2019)... ... , ... Biomeme, Inc. , a leading manufacturer of ... for performing PCR, RT-PCR, qPCR, and Isothermal tests called Franklin ™. The ... English chemist and X-ray crystallographer who made significant contributions to the understanding of ...
(Date:3/27/2019)... ... March 27, 2019 , ... In honor of National Nutrition Month, ... importance of healthy meals and good nutrition. This month, Chef Jodi Abel appeared ... chef. , The first segment addressed the nutritional value of USDA’s MyPlate, ...
Breaking Biology Technology:
(Date:4/17/2019)... ... 17, 2019 , ... USDM Life Sciences (USDM) announces that Jay Crowley, Vice ... for Creating a Sustainable Global UDI Compliance Strategy at the European UDI Forum on ... , What device manufacturers did to comply with the US FDA UDI rule ...
(Date:4/16/2019)... ... April 16, 2019 , ... ... and search firms with over $2 billion in placement fees to recruiters and ... and employee onboarding platform, ExactHire. , This strategic relationship with ExactHire is ...
(Date:4/16/2019)... Md. (PRWEB) , ... April 16, 2019 , ... ... announced its featured speakers for two signature events: The 2019 ISPE Biopharmaceutical ... Workshop on 20–21 June. Taking place in one of the most influential ...
Breaking Biology News(10 mins):